Mechanisms and enzymes involved in SARS coronavirus genome expression-Reference-Cited by-同舟云学术

Mechanisms and enzymes involved in SARS coronavirus genome expression

Published:2003-09-01 Issue:9 Volume:84 Page:2305-2315
ISSN:0022-1317
Container-title:Journal of General Virology
language:en
Short-container-title:

Author:

Thiel Volker¹,Ivanov Konstantin A.¹,Putics Ákos¹,Hertzig Tobias¹,Schelle Barbara¹,Bayer Sonja¹,Weißbrich Benedikt¹,Snijder Eric J.²,Rabenau Holger³,Doerr Hans Wilhelm³,Gorbalenya Alexander E.²,Ziebuhr John¹

Affiliation:

1. Institute of Virology and Immunology, University of Würzburg, Versbacher Str. 7, 97078 Würzburg, Germany

2. Molecular Virology Laboratory, Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands

3. Institute for Medical Virology, Johann Wolfgang Goethe University, Frankfurt (Main), Germany

Publisher

Microbiology Society

Subject

Virology

Reference51 articles.

1. Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain;Anand;EMBO J,2002

2. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs;Anand;Science,2003

3. Identification of a domain required for autoproteolytic cleavage of murine coronavirus gene A polyprotein;Baker;J Virol,1989

4. Characterization of a second cleavage site and demonstration of activity in trans by the papain-like proteinase of the murine coronavirus mouse hepatitis virus strain A59;Bonilla;J Virol,1997

5. Four proteins processed from the replicase gene polyprotein of mouse hepatitis virus colocalize in the cell periphery and adjacent to sites of virion assembly;Bost;J Virol,2000

Cited by 836 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design of novel and highly selective SARS-CoV-2 main protease inhibitors;Antimicrobial Agents and Chemotherapy;2024-09-03

2. Repurposing of antimycobacterium drugs for COVID-19 treatment by targeting SARS CoV-2 main protease: An in-silico perspective;Gene;2024-09

3. Targeting sgRNA N secondary structure as a way of inhibiting SARS-CoV-2 replication;Antiviral Research;2024-08

4. The Coronavirus helicase in replication;Virus Research;2024-08

5. Assay Development and Validation for Innovative Antiviral Development Targeting the N-Terminal Autoprocessing of SARS-CoV-2 Main Protease Precursors;Viruses;2024-07-29